Prescribing information

 

Cosentyx is indicated for the treatment of: moderate to severe plaque psoriasis in adults, adolescents and children from the age of 6 years who are candidates for systemic therapy; active psoriatic arthritis in adult patients, alone or in combination with MTX, when the response to previous DMARD therapy has been inadequate; active ankylosing spondylitis in adults who have responded inadequately to conventional therapy; active non-radiographic axial spondyloarthritis with objective signs of inflammation (CRP and/or MRI evidence) in adults who have responded inadequately to non-steroidal anti-inflammatory drugs.

What are the benefits of You First?

You First is a nurse-led service for Cosentyx patients, tailored to meet individual demands and designed to work alongside the expertise of the NHS healthcare team.

Did you know that in a recent survey 100% of Cosentyx patients receiving support from the You First support programme said they would recommend the service to friends and family?*1 It’s hardly surprising with a patient satisfaction rating of 99.84%.*1

How many Cosentyx patients has You First supported?

 

you-first-patients-supported-box

you-first-patients-enrolled-box

 
  • You First is for NHS patients who are receiving Cosentyx or for whom the prescribing decision has been made
  • A service level agreement is required for each NHS organisation participating
  • You First is a patient support programme developed and funded by Novartis Pharmaceuticals UK Limited

What does the You First programme offer?

 

 Image of the words '3 years' inside a rosette

The You First programme is offered for up to 3 years

 Image of two crossing arrows

The programme is a service tailored to the needs of both the trust and the patient

 Icon of 100% recommend

100% of You First patients would recommend the service to friends and family (n=465).*

 Icon showing 99.5% patient satisfaction

99.5% mean score for the politeness and professionalism of nurses (n=465).*

 

 Icon of a rosette

Can You First nurses provide the same high quality of service that we expect from our NHS nurses

You First nurses are experienced, NMC registered nurses. Each nurse receives specific training, competency assessment and validation. The You First programme adheres to all regulatory clinical standards. By building a relationship with the You First nurse, you will be able to make your own assessment of their skillset and decide the best way to work together.

Novartis are committed to helping patients achieve their goals and, as such, will work with you and your team to ensure You First services are tailored to meet the needs of you and your patients. If you would like to, contact your Novartis key account manager to organise a competency assessment of your dedicated You First nurse.

 

 Icon of a nurse

How do You First nurses differ from homecare nurses?

Whilst homecare nurses provide a valuable service administering treatments to patients, You First offers a longer term, more comprehensive set of services delivered by dedicated trained rheumatology and dermatology nurses, from phlebotomy and assessment scores to dietary advice and psychological support.

 

 Icon representing a document

How is patient information and data that are collected and/or shared for the purposes of the You First programme protected?

All You First nurses are trained to conduct accurate, relevant patient assessments, which are stored and shared securely via NHS networks. Information sharing and storing, like many aspects of the programme, can be tailored to suit local needs and processes. You First adheres to all regulatory clinical standards enforced by the CQC, the Care Inspectorate in Scotland and the RQIA in Northern Ireland.

 

 Icon of two people and speech bubbles above them

How do You First nurses communicate with the NHS team?

You First nurses will be working as part of the hospital team to enhance the patients’ experiences, being an extension of the service, not a separate one. Clinical assessments are shared with you and patient management issues are escalated in line with the centre’s protocols so you stay fully in control.

 

 Icon of a shield

What insurance or safeguards are in place should the programme be stopped?

Novartis is committed to You First and offer 3 year agreements for the programme, providing long-term reassurance that the support You First offers patients will be maintained.

 

 Icon of a pair of scales

How is equity of care maintained when not all patients will be eligible for this service?

You First can help improve the equity of care by allowing follow-up patients on Cosentyx to be managed at home without compromising appointments with new and complex patients in the clinic. You First also supports the NHS’s comprehensive model for personalised care by offering additional support to Cosentyx patients who need it.

 

Want to know more?

We would be delighted to take you through the programme, the sign up process, and answer any questions. Please get in touch by clicking here.

The You First team will respond to all enquiries within 48 hours.

 

*Patients rated the care they received from their You First nurse, provided by Bionical, on a scale of 0–4 (0 = very dissatisfied, 4 = very satisfied); the mean score was converted into a percentage (n=465).

CRP, c-reactive protein; DMARD, disease modifying anti-rheumatic drug; MRI, magnetic resonance imaging; MTX, methotrexate; NHS, National Health Service; NICE, National Institute of Health and Care Excellence; SMC, Scottish Medicines Consortium.

Reference

  1. Novartis Data on File Secukinumab You First DoF UK 1 – March 2021.
  2. Novartis Data on File. You First Account Data – February 2022.
Rate this content: 
No votes yet
UK | March 2022 | 173371
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]